current and emerging treatment options for anemia in mf
Published 10 months ago • 70 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
2:55
current and emerging treatments for mf: an update from ash 2023
-
3:47
current and emerging treatment options for lr-mds-associated anemia following esa failure
-
4:28
current and emerging treatment options for mds
-
2:00
the incorporation of immunotherapy into frontline all treatment
-
1:36
current and future treatment options for patients with myelofibrosis who have anemia
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
0:52
is there a role for combination therapy in cml?
-
2:16
current and future treatment approaches for hr-mds
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
1:20
the current standard of care for patients with lower-risk mds
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
2:16
the current state-of-the-art in mf and pv therapy and future outlooks
-
1:46
current treatment approaches in et and an insight into the surpass-et trial
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:14
an overview of the current and future treatment landscape for mpns
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023